Source: Cannmart.com
  • Sugarbud Craft Growers (SUGR) has introduced its first Cannabis 2.0 product offering
  • Sugarbud’s WC#11 Full Spectrum Oil (FSO) 0.5g vape cartridges are now available nationwide to registered medical patients on Cannmart.com, or in select retailers in Manitoba
  • Sugarbud is an Alberta-based, consumer-driven boutique craft cannabis company
  • CannMart Inc. is a wholly-owned subsidiary of Namaste Technologies, a marketplace platform for cannabis and wellness products
  • Sugarbud Craft Growers Corp. (SUGR) opened trading at C$0.045 per share

Sugarbud Craft Growers (SUGR) has expanded its Sugarbud Craft Cannabis Collection with the launch of its first Cannabis 2.0 product offering.

“We are very pleased to now include Cannabis 2.0 products in our Craft Cannabis Collection,” stated Sugarbud’s President and CEO, John Kondrosky.

“Our 100% cannabis, additive free vape products leverage and embody the exceptional flavour profiles and aromas that consumers have come to expect from our craft cannabis flower and are a natural and logical extension of our overall inhaled products strategy.”

Formulated from the company’s exclusive Wedding Cake #11 strain, Sugarbud’s WC#11 Full Spectrum Oil (FSO) 0.5g vape cartridges are now available nationwide to registered medical patients on Cannmart.com and in select private retail stores in Manitoba.

Sugarbud is an Alberta-based, consumer-driven boutique craft cannabis company focused on the cultivation and production of exceptionally high-quality products.

CannMart Inc. is a wholly-owned subsidiary of Namaste Technologies, a marketplace platform for cannabis and wellness products.

CannMart.com provides Canadian medical customers with a diverse selection of hand-picked products from a multitude of federally licensed cultivators and US customers with access to hemp-derived CBD and smoking accessories.

Sugarbud Craft Growers Corp. (SUGR) opened trading at C$0.045 per share.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.